Rallybio Corp. (RLYB)
16.84
+0.05
(+0.30%)
USD |
NASDAQ |
Sep 01, 16:00
16.84
0.00 (0.00%)
After-Hours: 19:30
Rallybio Cash and Short Term Investments (Quarterly) : 92.85M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.85M |
| March 31, 2026 | 46.80M |
| December 31, 2025 | 54.74M |
| September 30, 2025 | 59.32M |
| June 30, 2025 | 45.75M |
| March 31, 2025 | 54.50M |
| December 31, 2024 | 65.51M |
| September 30, 2024 | 75.14M |
| June 30, 2024 | 88.61M |
| March 31, 2024 | 94.18M |
| December 31, 2023 | 109.93M |
| September 30, 2023 | 121.38M |
| Date | Value |
|---|---|
| June 30, 2023 | 137.84M |
| March 31, 2023 | 150.39M |
| December 31, 2022 | 168.99M |
| September 30, 2022 | 132.42M |
| June 30, 2022 | 147.37M |
| March 31, 2022 | 161.41M |
| December 31, 2021 | 175.33M |
| September 30, 2021 | 186.98M |
| June 30, 2021 | 112.73M |
| March 31, 2021 | 127.74M |
| December 31, 2020 | 140.23M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Q32 Bio, Inc. | 106.27M |
| Beam Therapeutics, Inc. | 1.153B |
| C4 Therapeutics, Inc. | 253.66M |
| Cullinan Therapeutics, Inc. | 334.54M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |